Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18414472rdf:typepubmed:Citationlld:pubmed
pubmed-article:18414472lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:18414472lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:18414472lifeskim:mentionsumls-concept:C1414532lld:lifeskim
pubmed-article:18414472lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:18414472lifeskim:mentionsumls-concept:C1512554lld:lifeskim
pubmed-article:18414472lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18414472pubmed:issue8lld:pubmed
pubmed-article:18414472pubmed:dateCreated2008-4-16lld:pubmed
pubmed-article:18414472pubmed:abstractTextThe Fanconi gene family has a role in DNA repair and inactivation of FANCF has been proposed as a mechanism of sensitisation to platinum chemotherapy. This study sought to confirm this hypothesis in cell lines and a large series of ovarian cancer samples. Promoter methylation was assessed by methylation-sensitive polymerase chain reaction of FANCF in nine ovarian cancer cell lines and 74 ovarian cancer samples taken from patients entered on a trial of cisplatin-based chemotherapy. This study confirmed methylation-dependent silencing of FANCF in one out of nine ovarian cancer cell lines. Methylation of FANCF was demonstrated in 13.2% of 53 evaluable ovarian tumour samples. Progression-free survival gave an HR of 3.63 (95% CI: 1.54-8.54, P=0.0016) in favour of the unmethylated cases. There was no association with overall survival. This study does not support methylation-dependent silencing of FANCF as a mechanism of sensitisation to platinum-based chemotherapy in ovarian cancer.lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:languageenglld:pubmed
pubmed-article:18414472pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:citationSubsetIMlld:pubmed
pubmed-article:18414472pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18414472pubmed:statusMEDLINElld:pubmed
pubmed-article:18414472pubmed:monthAprlld:pubmed
pubmed-article:18414472pubmed:issn1532-1827lld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:SmithPPlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:GreenJ AJAlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:CoeneMMlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:HEYE NENlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:WongHHlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:CrookTTlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:SyedNNlld:pubmed
pubmed-article:18414472pubmed:authorpubmed-author:SzlosarekPPlld:pubmed
pubmed-article:18414472pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18414472pubmed:day22lld:pubmed
pubmed-article:18414472pubmed:volume98lld:pubmed
pubmed-article:18414472pubmed:ownerNLMlld:pubmed
pubmed-article:18414472pubmed:authorsCompleteYlld:pubmed
pubmed-article:18414472pubmed:pagination1452-6lld:pubmed
pubmed-article:18414472pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:meshHeadingpubmed-meshheading:18414472...lld:pubmed
pubmed-article:18414472pubmed:year2008lld:pubmed
pubmed-article:18414472pubmed:articleTitlePromoter hypermethylation of FANCF and outcome in advanced ovarian cancer.lld:pubmed
pubmed-article:18414472pubmed:affiliationDivision of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK.lld:pubmed
pubmed-article:18414472pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18414472pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2188entrezgene:pubmedpubmed-article:18414472lld:entrezgene
entrez-gene:499155entrezgene:pubmedpubmed-article:18414472lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18414472lld:entrezgene
lhgdn:association:44743lhgdn:found_inpubmed-article:18414472lld:lhgdn